A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes

NCT04855292 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: TG103 injection
DRUG: Placebo

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.